In addition it addresses the FDA’s communications While using the applicant, the retention of data that help the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer ownership of the SE report back to a different applicant and Digital submission with the SE report and